Mission statement · Company scope
“Our mission is to transform the ear, nose and throat ("ENT") treatment paradigm by utilizing our proprietary technology to develop safe and effective therapies for the treatment of CRS.”
In use2025 – now1 sighting
First seenMar 2025Added
Last seenMar 2025Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Innovation (primary) · Impact
- Leads with
- Invention
- Best for
- Climate & health
- Formula
- We’re building [new thing] so [result]
- Tone
- Technical
- Length
- 29 words · reading grade 16.1
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.75
- Record
- st_972785744b9b9396
- Classification confidence
- 0.69
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2025-03-13 · sec_sentence · 10-K · accession 0000950170-25-038751
View filing ↗0 to compareCompare